NCBiotech News

First Flight Venture Center’s unique RTP prototyping facility, Hangar6, has landed a $2.6 million federal grant to help it keep building on its success.

As Senior Director of Science & Technology Development at the North Carolina Biotechnology Center, Tracey du Laney helps to bring scientific expertise and companies to North Carolina to drive life sciences research and economic development.

Morrisville-based precision health company Metabolon has just closed the books on $72 million in new combined debt and equity financing.

Burlington-based LabCorp has developed the first testing method to simultaneously detect for COVID-19, influenza A / B, and respiratory syncytial virus (RSV) just in time for the upcoming flu season.

Cellex, a medical diagnostics company with U.S. headquarters and labs in Research Triangle Park, has launched a new antibody test for detecting COVID-19 infection.

Winston-Salem regenerative medicine company Plakous Therapeutics has landed an award of up to $1,725,000 to help it develop a novel therapy targeting a rare disease in premature babies.

Morrisville-based Liquidia Technologies has filed a New Drug Application with the FDA for LIQ861, an inhaled dry powder using its micro-particle engineering technology to treat patients with pulmonary arterial hypertension.

By Barry Teater, NCBiotech Writer

NC bioscience companies getting federal SBIR/STTR R&D funding will soon have a chance to win matching funds from the state, thanks to new funding for the One NC Small Business Program.

San Diego-based Illumina, which founded GRAIL in 2016 and then spun it off as a standalone business, is now buying the unique cancer-testing company, with plans for a Durham factory, for $8 billion.

The University of North Carolina at Chapel Hill and BASF Corporation are joining forces to address global challenges.

Syngenta has donated four custom plant growth chambers valued at $1.5 million to NC State's Plant Sciences Initiative.

RTP medical device company TransEnterix is establishing the first Asia-Pacific training center for its Senhance Surgical System at the Saitama Medical University International Center in Tokyo.

Biogen announces a $250 million, 20-year initiative – Healthy Climate, Healthy Lives – to eliminate fossil fuel emissions across all its operations by 2040.

The innovative California-based cancer-detection company GRAIL, Inc., which is establishing a $100 million-plus facility in Research Triangle Park, is preparing to go public.